SCHEMBL6607258

SCHEMBL6607258

COc1cc(N)c(-c2ncnc(-n3c(Cl)nc4ccccc43)n2)c(OC)c1OCCN1CCOCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.43
KDR P35968 4/20 0.41
LCK P06239 2/20 0.41
SRC P12931 1/20 0.41
PDE2A O00408 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
EGFR P00533 4/20 0.39
FGFR1 P11362 1/20 0.39
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
EPHA2 P29317 1/20 0.38
EPHB4 P54760 1/20 0.38
LMNA P02545 2/20 0.38
ATM Q13315 1/20 0.38
PDPK1 O15530 1/20 0.37
MAPK14 Q16539 1/20 0.37
ADCY10 Q96PN6 1/20 0.37
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6600560 0.94 PDE2A (0.40) SYKKDRSRCPDE2AMKNK1
SCHEMBL6493240 0.82 KDR (0.56) SYKKDRLCKSRCEGFR
SCHEMBL6479597 0.80 KDR (0.57) KDRLCKSRCEGFRFGFR1
SCHEMBL14380859 0.67 KDR (0.51) KDRLCKSRCMKNK1EGFR
SCHEMBL6478952 0.66 KDR (0.74) KDRLCKSRCEGFRFGFR1
SCHEMBL12435658 0.66 SYK (0.77) SYKCYP2D6TSHRHTR2CHTR2B
SCHEMBL4088385 0.65 SYK (0.59) SYKKDRCYP2D6TSHREPHA2
SCHEMBL2088116 0.64 SYK (0.65) SYKSRCCYP2D6TSHRHTR2C
SCHEMBL6479352 0.64 KDR (0.54) KDRLCKSRCEGFRFGFR1
SCHEMBL18167155 0.64 SYK (0.47) SYKKDRLCKSRCEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385833-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS Amgen Inc. (US) 2004-02-04 EP disclosed
WO-2002083654-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed